Navigation Links
Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
Date:2/11/2008

YOKNEAM, Israel, Feb. 11 /PRNewswire/ -- Lumenis(R) Ltd. announced today that it has scheduled a special general meeting of shareholders to seek approval and authorization, in accordance with the Israeli Companies Law, of a proposed settlement of the securities class action litigation that has been pending against the Company in the federal court in New York since 2002. Under the terms of the proposed settlement, which has been agreed to in principle by Lumenis and the lead plaintiffs on behalf of the class, a total of $20.1 million would be contributed to a settlement fund for the benefit of the class. While Lumenis itself would contribute a portion of this fund, the major portion would be paid on behalf of the defendants by the Company's insurers.

Assuming shareholder approval is forthcoming, the settlement will still be subject to a number of conditions, including the execution and preliminary court approval of a definitive stipulation of settlement, and final court approval after there has been notice to the members of the class and a hearing as to the fairness of the proposed settlement. If the settlement is finally approved by the court, the class action litigation will be dismissed with prejudice against Lumenis and the former Lumenis officers and directors who have been named as defendants.

About Lumenis Ltd.

Lumenis is Israel's largest medical device company with more than 1,000 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. In December 2006, a group led by a private equity consortium LM Partners LP and Ofer Hi-Tech Group invested approximately $150 million in the Company.

Contact:

Michelle Maydan

Director of Corporate Communications

1-866-569-0597

+972-4-959-9004

e
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
3. URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs
4. NIH panel seeks to dispel stigma associated with fecal and urinary incontinence
5. Group Seeks Refinement of Knee Arthritis Treatment Guidelines
6. The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off States Existing Six-Year Surcharge Period
7. Leading neuroscientist seeks beauty, love and happiness
8. American Cancer Society Seeks Volunteers to Help Decide Who Gets Research Grants
9. FDA Seeks Food Recall Authority
10. Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages
11. New Legislation Seeks to Improve Access to Community Mental Healthcare

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...American Seminars Inc. is now accepting medical fa...ation courses at their medical facility in 2010. T...ation and capabilities to the medical community as...ir physical therapy and occupational therapy team ...0 live training events. , ...
(Date:12/4/2009)...r fasciitis heel pain affects over two million peo...py has been cited by the American Academy of Ortho...In response to these findings, Orthotics And Beyon...py systems for plantar fasciitis treatment as a co...herapies. , (PRWEB) Decem...
(Date:12/4/2009)...nowned Center for mind-body medicine founded by De... immuno-boosting herbal supplement based on the ti... San Diego, California (PRWEB) Dece...ss due to factors such as stress, inactivity, dise...e around the world are looking for natural ways to...
(Date:12/3/2009)...3 The American Red Cros...tional Brotherhood of Teamsters, Local 929 after i... the facility, interfering with blood shipments to...m.com/cgi-bin/prnh/20081216/DC52619LOGO ) ,, T... American Red Cross Blood Services Penn-Jersey Reg...
(Date:12/3/2009)... membership increase of more than 15 percent since...a milestone in its history, but also as a sign of ...ons are experiencing a decline in membership due t...rade organizations across the nation are suffering...cedented growth, signaling that physicians see con...
Breaking Medicine News(10 mins):Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2Health News:Florida Medical Association Marks Record Membership Growth 2
...April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- Chi...s: CBIU), a leading company,in the Nano-BioTech In...y,and product lines. The company presently produce...onal attention with,the introduction of an Influen...
...ls crafted based on California Legislative Blue Ri...ort, SACRAMENTO, Calif., April 2, 2008 Lawmakers...f eight bills to address,the issues related to the...t 11:00am. The bills were inspired by a,report iss...
...l 1, 2008 /PRNewswire-USNewswire/-- The Toy Indust...day regarding the new,Washington State law governi...Governor vetoed two key parts of the bill,and issu...gning statement, the Governor is committed to fixi...
...., April 1, 2008 Gregory A. Adams has,been named ...iser,Foundation Health Plan, Inc., and Kaiser Foun...nard J. Tyson, executive vice president of Kaiser,...ontinue to serve as national senior vice president...
...., April 1, 2008 Hawaii has one of the,most pleas...hink that,Hawaiians never have trouble with their ... have a deep knowledge of skin care that goes back... Natural Elements offers a complete line of natur...
...Minn. -- Obesity is more than a cosmetic concern b...high blood pressure, diabetes and many other serio...ming more calories than you expend through exercis...ify additional factors that affect a persons tende...
Other Medicine News:Health News:China Bionanometer Industries (CBIU) Describes their Current Production Capacity and Product Lines 2Health News:California Lawmakers Unveil Legislative Effort on Autism 2Health News:The Toy Industry Association Responds to Washington State Law Governing the Sale of Toys and the Governor's Veto of Key Sections of the Bill 2Health News:Gregory A. Adams Named Northern California Region President of Kaiser Foundation Health Plan and Hospitals 2Health News:Gregory A. Adams Named Northern California Region President of Kaiser Foundation Health Plan and Hospitals 3Health News:Natural Elements Reveals Exotic Natural Hawaiian Skin Care Products for Sale on Their Website 2Health News:Mayo Clinic Proceedings examines link between bacteria in the digestive system and obesity 2Health News:Mayo Clinic Proceedings examines link between bacteria in the digestive system and obesity 3
(Date:12/4/2009)...re-FirstCall/ -- AstraZeneca (NYSE: AZN ) today ... (FDA) has approved once-daily SEROQUEL XR® (...djunctive (add-on) treatment to antidepressants in...QUEL XR is the only medication in its class approv...der as adjunctive therapy and acute depressive epi...
(Date:12/3/2009)...LEGE, Pa., Dec. 3 Ambry Genetics a...agreement to provide extended bioinformatics genom... for next-generation sequencing projects performed.../cgi-bin/prnh/20090428/LA06744LOGO ) ,, Anja Ka...y has been providing genomics solutions on Illumin...
(Date:12/3/2009)...tCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR )...ase with Regeneron Pharmaceuticals, Inc. (Nasdaq: ...dditional, newly-constructed laboratory and office...town, New York. The new lease expires on June 30, ... approximately two months after BioMed and Regener...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 1Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 2Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 5Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 6Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 7Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 8Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 9Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 10Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 11Finding a protective mechanism for retinal cells could save sight 14859 1Finding a protective mechanism for retinal cells could save sight 14859 2Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2
...ch 28 Boston Scientific Corporation (NYSE: BSX ...omic and quality of life outcomes, based on one-ye...ts found that while the overall cost effectiveness...s coronary artery bypass graft (CABG) surgery vari...ore cost effective than CABG in patients with low ...
...utics (NYSE Amex: CXM ) today reported on an NIH...nt researchers at the University of Cincinnati e...lls Accelerate Bone Marrow Stem Cell Mobilization ... Promote Myocardial Repair that was published in ...ion Research ( Circ Res. 2008; 103(11): 1300-130...
Other Medicine Technology:SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 2SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 3SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 4SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 5Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack 2Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack 3Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack 4Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack 5Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack 6
Selenia
...DA approved, and represents a breakthrough in earl...y mammography system to offer 25-micron native dia...an's larger field of view accommodates more patien...and helps reduce motion during exposure. And its p...
...evice designed to handle the intense processing lo...demands of the EEG laboratory. Advanced recording ...ze workflow and the collection, evaluation and arc... search capability keeps track of every patient en...
Integra Epilepsy Sphenoidal Electrodes
Medicine Products: